StockWatch
·
Biotechnology: Commercial Physical & Biological Resarch
Corporate ActionJul 6, 2026, 05:22 PM

iSpecimen Files S-1/A for Offering of Shares & Pre-Funded Warrants

AI Summary

iSpecimen Inc. filed an Amendment No. 1 to its Form S-1 registration statement for a public offering of up to 1,515,152 shares of common stock and up to 1,515,152 pre-funded warrants. The assumed public offering price is $2.64 per share, with pre-funded warrants exercisable at $0.0001 per share. The amendment clarifies the use of proceeds, noting that "outstanding debt" refers to accounts payable and accrued obligations, and allocates approximately $700,000 for potential acquisitions.

Key Highlights

  • Offering up to 1,515,152 shares of common stock.
  • Offering up to 1,515,152 pre-funded warrants.
  • Assumed public offering price of $2.64 per share.
  • Pre-funded warrant exercise price of $0.0001 per share.
  • Use of proceeds clarified for outstanding debt (accounts payable) and $700,000 for potential acquisitions.
  • Placement agent to receive 4% cash fee of gross proceeds plus expenses.
  • Company is a non-accelerated filer, smaller reporting company, and emerging growth company.